 | Up a level |
Group by: Item Type | No Grouping
Number of items: 1.
Holida, Myrl, Linhart, Aleš, Pisani, Antonio, Longo, Nicola, Eyskens, François, Goker‐Alpan, Ozlem, Wallace, Eric, Deegan, Patrick, Tøndel, Camilla, Feldt‐Rasmussen, Ulla, Hughes, Derralynn, Sakov, Anat, Rocco, Rossana, Almon, Einat Brill, Alon, Sari, Chertkoff, Raul, Warnock, David G., Waldek, Stephen, Wilcox, William R. and Bernat, John A. (2024) A phase III, open‐label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies. Journal of Inherited Metabolic Disease. ISSN 1573-2665